Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer’s Disease Clinical Trial Recruitment

INTRODUCTION: The apolipoprotein E (APOE) gene is the strongest known genetic risk factor for sporadic Alzheimer’s disease (AD). APOE can be used as an enrichment strategy or inclusion criterion for AD prevention trials. Personal genomics companies market direct-to-consumer (DTC) genetic tests, incl...

Full description

Saved in:
Bibliographic Details
Published in:Alzheimer Dis Assoc Disord
Main Authors: Ryan, Mary M., Cox, Chelsea G., Witbracht, Megan, Hoang, Dan, Gillen, Daniel L., Grill, Joshua D.
Format: Artigo
Language:Inglês
Published: 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8044253/
https://ncbi.nlm.nih.gov/pubmed/33060367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WAD.0000000000000421
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items